Revance Therapeutics, Inc.

Home » Revance Therapeutics, Inc.

Secondary

Revance Therapeutics, Inc.

Revance is a clinical-stage biotechnology company focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications.

Symbol

RVNC

Last Closing Price
$33.65

Shares
5,000,000

Effective Date
December 7, 2017

Underwriters
Goldman Sachs, Cowen

To view the prospectus for Revance Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253